Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Transverse Myelitis Companies

ID: MRFR/MED/5028-HCR
90 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Transverse Myelitis companies are at the forefront of addressing this rare neurological disorder. Through dedicated research, development, and distribution, these organizations provide innovative treatments, contributing to improved outcomes and quality of life for individuals affected by transverse myelitis.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Transverse Myelitis Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.5%
2024 Market Size$ 0.21 Billion
2025 Market Size$ 0.23 Billion
2035 Market Size$ 0.43 Billion
Key Players
Biogen
Novartis
Roche
Sanofi
Merck
Pfizer
Opportunities
  • Advancements in Diagnostic Techniques
  • Enhanced Patient Support and Advocacy
  • Rising Incidence of Autoimmune Disorders

Top Industry Leaders in the Transverse Myelitis Market

Transverse Myelitis Market
 

Latest Transverse Myelitis Companies Updates:

Annexon Biosciences (NASDAQ: ANEX): Announced positive Phase 2b data for their cannabinoid CB2 receptor agonist, CB2A-129, in treating acute optic neuritis, a condition often associated with transverse myelitis.

Viela Bio (Viela Bio): Initiated a Phase 2 clinical trial evaluating their anti-IL-17A antibody, inebilizumab, for treating neuromyelitis optica spectrum disorder (NMOSD), a condition sometimes overlapping with transverse myelitis.

Rare Disease Foundation: Launched a new initiative to raise awareness and support research for transverse myelitis and other rare neurological disorders.

List of Transverse Myelitis companies in the market:

  • Medtronic, Inc.
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Baxter International, Inc.
  • Amgen Inc.
  • Johnson & Johnson Consumer Inc.
  • Bayer AG
  • Pfizer, Inc.
  • Cerus Corporation